This is the mail archive of the ecos-bugs@sources.redhat.com mailing list for the eCos project.


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]
Other format: [Raw text]

Hidden market gems help get a leg up


                                               HOT SHOT ST0CK ALERT
                                      EXCITING  ISSUE PGCN  GET IN NOW!!!
                                       ONLINE OFFERING! Tuesday June 14th

                                               SYMBOL:  PGCN

Current Price: $2.00 (UP 1.00 (100.00%) Monday Alone)

  Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability, pioneered
medicine products, and well-established marketing network.

Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US$120,000. Currently
it has 60 employees, 20 of them are professionals and experts on diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of
new medicines, particularly those on diabetes.

Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.

PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China, agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing through
the company's website. The marketing network of PINGCHUAN covers more than
50% districts of China and exports to US, Japan, Russia, and south-eastern
Asia.

Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30
over 400 PERCENT !!!  But We expect much more from PGCN, Sit back and watch.

Information 
within this email contains "forwardloking statements" within the meaning of 
Section 27Aof the Securities Act of 1933 and Section 21B of 
theSecurities Exchange Act of 1934. Any statements that express or 
involve discussions with respect to predictions, expectations, beliefs, 
plans,projections, objectives, goals, assumptions or future events or 
performance are not statements of historical fact and may be "forward looking 
statements."Forwardloking statements are based on 
expectations,estimates and projections at the time the statements are 
made that involve a number of risks and uncertainties which could cause 
actual results or events to differ materially from those 
presently anticipated. Forward looking statements in this action may be 
identified through the use of words such as"projects", "foresee", "expects", 
"will,""anticipates," "estimates," "believes," "understands"or that by 
statements indicating certain actions"may," "could," or "might" occur. 
 Risk factors include general economic and business conditions, the ability to 
acquire and develop specific projects, the ability  to fund operations and 
changes in consumer and business consumption habits and other factors 
overwhich the company has little or no control. The publisher of this 
newsletter does not represent that the information contained in this message 
states all material facts or does not omit a material fact necessary to 
make the statements therein not misleading. All information provided within 
this email pertaining to investing, stocks, securities must be understood 
as information provided and not investment advice. The publisher of this 
newsletter advises all readers and subscribers to seek advice from 
a registered professional securities representative before deciding to 
trade in stocks featured within this email. None of the material within this 
report shall be construed as any kind of investment advice 
or solicitation. Many of these companies are on the verge of bankruptcy. 
You can lose all your money by investing in this stock. We urge you to read 
the company's SEC filings now, before you invest. The publisher of this 
newsletter is not a regstered invstment advisor. Subscribers should not 
view information herein as legal, tax, accounting or investment 
advice. In compliance with the SecuritiesAct of 1933, Section 
17(b),The publisher of this newsletter is contracted to receive free 
trading shares from a third party, not an officer,director or 
affiliate shareholder for the circulation of this report. Be aware of an 
inherent conflict of interest resulting from such compensation due to 
the fact that this is a paid advertisement and is not without bias.The 
party that paid us has a position in the stock they will sell at anytime 
without notice.This could have a negative impact on the price of 
the stock, causing you to lose money. All factual information in this 
report was gathered from public sources, including but not limited to SEC
 filings,Company Websites and Company Press Releases. The publisher of 
this newsletter believes this informationto be reliable but can make no 
guarantee as to its accuracy or completeness. Use of the material 
within this email constitutes your acceptance of these terms.



Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]